News & Deep Analysis
ADMA

ADMA BIOLOGICS CFO Retirement — Terry Kohler Named

Published: February 25, 2026
ADMA BIOLOGICS, INC.

Direct News

  • Ticker: ADMA
  • CFO Brad Tade retires (announcement dated Feb 25, 2026).
  • Terry Kohler appointed as Chief Financial Officer and Treasurer.
  • Company announced leadership change on Feb 25, 2026.

Historical Context

This leadership change follows ADMA BIOLOGICS' Q3 2025 Financial Results and Business Update, including an FDA lot release, reported on Nov 5, 2025. That update is the most recent operational and financial milestone disclosed prior to the Feb 25, 2026 announcement. Investors may view the CFO transition against the backdrop of those results when assessing near-term financial stewardship and reporting continuity.

What investors need to know

ADMA BIOLOGICS announced the retirement of CFO Brad Tade and the appointment of Terry Kohler as CFO and Treasurer on Feb 25, 2026. The change is a material executive transition affecting the company's finance leadership. For investors, the immediate considerations are continuity in financial reporting, treasury management and any guidance tied to recent results. The company has named Kohler to hold both the CFO and Treasurer roles, consolidating responsibility for financial strategy and capital oversight under a single executive. Market participants typically watch for follow-up communications from the company on transition timing, delegation of duties, and any impact on near-term financial disclosures or capital plans. Absent further company statements, the disclosed facts are limited to the retirement and appointment announced today.

Investor FAQ

The most effective approach is to maintain a factual perspective. Keep a close watch on further developments at ADMA BIOLOGICS, INC. as they unfold. Use primary source data to validate your investment thesis rather than relying on delayed secondary reports.

You can set up an automated tracker on Portrak. Our system monitors official SEC filings in real-time, delivering the most critical insights to your phone or inbox seconds after publication—frequently before the information reaches major financial news platforms.

We believe quality intelligence should be accessible. Our business model is supported by professional investors with large, complex portfolios who utilize Portrak Pro. These users pay to automate the monitoring of extensive watchlists, saving hundreds of hours in research time, which allows us to keep the standard service free for individual investors tracking their core positions.

Setting up your automated intelligence pipeline is a simple 3-step process:

1

Create Your Free Account

Sign up or log in to access your personal dashboard.

2

Select Your Focus

Use the search bar to find companies like ADMA BIOLOGICS, INC.. Choose between monitoring specific events or receiving general market-moving intelligence. Our AI automatically determines what’s critical based on real-time market data and the company’s current profile.

3

Receive Real-Time Intelligence

Once activated, all official filings are analyzed instantly. Insights are delivered directly to your email or as a push notification if you use the Portrak mobile app.

Also available as a mobile app for iOS & Android—search for "Portrak"

More Strategic Insights